UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural ...

Today, on World Bronchiectasis Day, the American Lung Association is launching a new campaign to support people living with bronchiectasis, which is a chronic and progressive lung condition that ...

TOKYO -- German drugmaker Boehringer Ingelheim plans to invest a total of 300 million euros ($346 million) in its plant in Japan from 2023 to 2028 as it moves to make the facility a production base ...

Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence ...

Total adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function.

Boehringer Ingelheim launches innovative poultry vaccine in India, offering single-dose protection against major diseases, ...

The site was created by Boehringer Ingelheim after a survey identified knowledge gaps among owners on many health topics ...

Altimmune’s pemvidutide failed to significantly improve fibrosis in MASH patients in a Phase IIb study. The biotech crashed ...

What happens when data projects forget the people who use them? A Disconnect. Boehringer Ingelheim turned things around by ...